{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T14:29:08Z","timestamp":1716906548842},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,10]]},"DOI":"10.7759\/cureus.33612","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T20:02:05Z","timestamp":1673380925000},"source":"Crossref","is-referenced-by-count":2,"title":["Myocardial Infarction as an Initial Presentation of Essential Thrombocythemia With Calreticulin (CALR) Mutation (None Type 1, None Type 2)"],"prefix":"10.7759","author":[{"given":"Mohammad","family":"Afana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Abu-Tineh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Ellahie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deena","family":"Sideeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afaf","family":"Albattah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A","family":"Yassin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/17562864221092093","article-title":"Essential thrombocythemia with CALR mutation and recurrent stroke: two case reports and literature review","volume":"15","author":"Chen R","year":"2022","unstructured":"Chen R, Shi X, Wang L, et al.. Essential thrombocythemia with CALR mutation and recurrent stroke: two case reports and literature review. Ther Adv Neurol Disord. 2022, 15:17562864221092093. 10.1177\/17562864221092093","journal-title":"Ther Adv Neurol Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3004","article-title":"MERGE: a multinational, multicenter observational registry for myeloproliferative neoplasms in Asia, including Middle East, Turkey, and Algeria","volume":"9","author":"Yassin MA","year":"2020","unstructured":"Yassin MA, Taher A, Mathews V, et al.. MERGE: a multinational, multicenter observational registry for myeloproliferative neoplasms in Asia, including Middle East, Turkey, and Algeria. Cancer Med. 2020, 9:4512-26. 10.1002\/cam4.3004","journal-title":"Cancer Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023088","article-title":"A study of 18F-FLT positron emission tomography\/computed tomography imaging in cases of prefibrotic\/early primary myelofibrosis and essential thrombocythemia","volume":"99","author":"Yassin MA","year":"2020","unstructured":"Yassin MA, Nehmeh SA, Nashwan AJ, et al.. A study of 18F-FLT positron emission tomography\/computed tomography imaging in cases of prefibrotic\/early primary myelofibrosis and essential thrombocythemia. Medicine (Baltimore). 2020, 99:e23088. 10.1097\/MD.0000000000023088","journal-title":"Medicine (Baltimore)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i21.7422","article-title":"Essential thrombocythemia with non-ST-segment elevation myocardial infarction as the first manifestation: a case report","volume":"10","author":"Wang ZM","year":"2022","unstructured":"Wang ZM, Chen WH, Wu YM, Wang LQ, Ye FL, Yin RL. Essential thrombocythemia with non-ST-segment elevation myocardial infarction as the first manifestation: a case report. World J Clin Cases. 2022, 10:7422-8. 10.12998\/wjcc.v10.i21.7422","journal-title":"World J Clin Cases"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.840906","article-title":"Case report: a rare case of acute anterior myocardial infarction simultaneously associated with aortic mural thrombosis due to essential thrombocytosis","volume":"9","author":"Ye S","year":"2022","unstructured":"Ye S, Xia WJ, Chen P. Case report: a rare case of acute anterior myocardial infarction simultaneously associated with aortic mural thrombosis due to essential thrombocytosis. Front Cardiovasc Med. 2022, 9:840906. 10.3389\/fcvm.2022.840906","journal-title":"Front Cardiovasc Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4032","article-title":"Acute ST-segment elevation myocardial infarction as the first manifestation of essential thrombocytosis","volume":"11","author":"Sharma P","year":"2019","unstructured":"Sharma P, Gupta S, Patel P, Zhang Y, Peles S. Acute ST-segment elevation myocardial infarction as the first manifestation of essential thrombocytosis. Cureus. 2019, 11:e4032. 10.7759\/cureus.4032","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V122.21.4054.4054","article-title":"Efficacy and safety of pegelated interferon alpha2a once monthly compared to once weekly dose in patients with essential thrombocythemia","volume":"122","author":"Yassin MA","year":"2013","unstructured":"Yassin MA, Al-Dewik NI, ElAyoubi H, Cassinat B. Efficacy and safety of pegelated interferon alpha2a once monthly compared to once weekly dose in patients with essential thrombocythemia. Blood. 2013, 122:4054.","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-99-113248","article-title":"Impact of myeloproliferative neoplasms (MPNs) on health-related quality of life (HRQOL) and medical resource utilization: results from the MERGE registry","volume":"132","author":"Taher A","year":"2018","unstructured":"Taher A, Yassin MA, Xiao Z, et al.. Impact of myeloproliferative neoplasms (MPNs) on health-related quality of life (HRQOL) and medical resource utilization: results from the MERGE registry. Blood. 2018, 132:4311.","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/161764","article-title":"Calreticulin mutated essential thrombocythemia presenting as acute coronary syndrome","volume":"2015","author":"Nazha B","year":"2015","unstructured":"Nazha B, Garcia G, Kandov R, Odaimi M. Calreticulin mutated essential thrombocythemia presenting as acute coronary syndrome. Case Rep Hematol. 2015, 2015:161764. 10.1155\/2015\/161764","journal-title":"Case Rep Hematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2020.1869712","article-title":"CALR-ETdb, the database of calreticulin variants diversity in essential thrombocythemia","volume":"33","author":"El Jahrani N","year":"2022","unstructured":"El Jahrani N, Cretin G, de Brevern AG. CALR-ETdb, the database of calreticulin variants diversity in essential thrombocythemia. Platelets. 2022, 33:157-67. 10.1080\/09537104.2020.1869712","journal-title":"Platelets"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23685","article-title":"Thrombosis and survival in essential thrombocythemia: a regional study of 1,144 patients","volume":"89","author":"Montanaro M","year":"2014","unstructured":"Montanaro M, Latagliata R, Cedrone M, et al.. Thrombosis and survival in essential thrombocythemia: a regional study of 1,144 patients. Am J Hematol. 2014, 89:542-6. 10.1002\/ajh.23685","journal-title":"Am J Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-07-659060","article-title":"Clinical and molecular response to interferon-\u03b1 therapy in essential thrombocythemia patients with CALR mutations","volume":"126","author":"Verger E","year":"2015","unstructured":"Verger E, Cassinat B, Chauveau A, et al.. Clinical and molecular response to interferon-\u03b1 therapy in essential thrombocythemia patients with CALR mutations. Blood. 2015, 126:2585-91. 10.1182\/blood-2015-07-659060","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v92i6.12180","article-title":"Myasthenia gravis and myeloproliferative neoplasms - mere association or paraneoplastic neurologic syndrome: a mini-review","volume":"92","author":"Sasi S","year":"2022","unstructured":"Sasi S, Mohamed M, Chitrambika P, Yassin MA. Myasthenia gravis and myeloproliferative neoplasms - mere association or paraneoplastic neurologic syndrome: a mini-review. Acta Biomed. 2022, 92:e2021437. 10.23750\/abm.v92i6.12180","journal-title":"Acta Biomed"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v92i6.12350","article-title":"Osteolytic bone lesions in patients with primary myelofibrosis: a systematic review","volume":"92","author":"Battukh N","year":"2022","unstructured":"Battukh N, Ali E, Yassin M. Osteolytic bone lesions in patients with primary myelofibrosis: a systematic review. Acta Biomed. 2022, 92:e2021478. 10.23750\/abm.v92i6.12350","journal-title":"Acta Biomed"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.25953","article-title":"The outcome of fatherhood in patients with Philadelphia-negative myeloproliferative neoplasms: a single-institution experience","volume":"14","author":"Ali EA","year":"2022","unstructured":"Ali EA, Abu-Tineh M, Rozi W, et al.. The outcome of fatherhood in patients with Philadelphia-negative myeloproliferative neoplasms: a single-institution experience. Cureus. 2022, 14:e25953. 10.7759\/cureus.25953","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2018.12.009","article-title":"Clinical Exome Sequencing unravels new disease-causing mutations in the myeloproliferative neoplasms: a pilot study in patients from the state of Qatar","volume":"689","author":"Al-Dewik N","year":"2019","unstructured":"Al-Dewik N, Ben-Omran T, Zayed H, Trujillano D, Kishore S, Rolfs A, Yassin MA. Clinical Exome Sequencing unravels new disease-causing mutations in the myeloproliferative neoplasms: a pilot study in patients from the state of Qatar. Gene. 2019, 689:34-42.","journal-title":"Gene"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/127716-myocardial-infarction-as-an-initial-presentation-of-essential-thrombocythemia-with-calreticulin-calr-mutation-none-type-1-none-type-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:47Z","timestamp":1707508787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/127716-myocardial-infarction-as-an-initial-presentation-of-essential-thrombocythemia-with-calreticulin-calr-mutation-none-type-1-none-type-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.33612","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,10]]}}}